Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial (T-TRANSPORT)
Transdermal Testosterone Gel for Poor Ovarian Responders. A Multicenter Double-blind Placebo Controlled Randomized Trial
Sponsor: Fundacion Dexeus
Terminated
Having reached the sample size described for the interim analysis and having seen the post-interim results, the sponsor has decided to stop the trial due to futility.
Other terminated trials from Fundacion Dexeus
Other Infertility trials with similar outcome
Listed as NCT02418572, this PHASE3 trial focuses on Infertility and Poor Ovarian Response and remains terminated or withdrawn. Sponsored by Fundacion Dexeus, it has been updated 10 times since 2015, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
10 versions recorded-
Jan 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Jan 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jun 2024 — Jul 2024 [monthly]
Terminated PHASE3
Status: Recruiting → Terminated
-
Jun 2023 — Jun 2024 [monthly]
Recruiting PHASE3
▶ Show 5 earlier versions
-
Nov 2021 — Jun 2023 [monthly]
Recruiting PHASE3
-
Jan 2021 — Nov 2021 [monthly]
Recruiting PHASE3
-
Jan 2020 — Jan 2021 [monthly]
Recruiting PHASE3
-
Jun 2018 — Jan 2020 [monthly]
Recruiting PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Recruiting PHASE3
First recorded
Apr 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fundacion Dexeus
For direct contact, visit the study record on ClinicalTrials.gov .